Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7066 AL 7080

Alzheimer's Disease, β-Amyloid Peptides, and Ubiquitin-Proteasome System: Nutritherapeutic Insights

Simon PYR, David R.

Neurodegener Dis. 2025;25(2):76-87. doi: 10.1159/000545170. Epub 2025 Mar 25.

Advancements in Proteolysis Targeting Chimeras for Targeted Therapeutic Strategies in Alzheimer's Disease

Zhou Q, Wang W, Deng C.

Mol Neurobiol. 2025 Aug;62(8):9686-9709. doi: 10.1007/s12035-025-04838-0. Epub 2025 Mar 25.

Cholesterol-modifying strategies for Alzheimer disease: promise or fallacy?

Azarfar K, Decourt B, Sanchez Camacho B, Lawrence JJ, Omondi TR, Sabbagh MN.

Expert Rev Neurother. 2025 May;25(5):521-535. doi: 10.1080/14737175.2025.2483928. Epub 2025 Apr 3.

Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's disease

Ruthirakuhan M, Guan DX, Mortby M, Gatchel J, Babulal GM.

Alzheimers Dement. 2025 Mar;21(3):e70079. doi: 10.1002/alz.70079.

Cholinesterase-based inhibitors as multitarget small molecules for the therapy of Alzheimer's disease

Marco-Contelles JL, Oset-Gasque MJ.

Chem Biol Interact. 2025 May 25;413:111497. doi: 10.1016/j.cbi.2025.111497. Epub 2025 Mar 28.

New insight into the role of altered brain cholesterol metabolism in the pathogenesis of AD: A unifying cholesterol hypothesis and new therapeutic approach for AD

Yang X, Yao K, Zhang M, Zhang W, Zu H.

Brain Res Bull. 2025 May;224:111321. doi: 10.1016/j.brainresbull.2025.111321. Epub 2025 Mar 29.

Immune modulation to treat Alzheimer's disease

Duggan MR, Morgan DG, Price BR, Rajbanshi B, Martin-Peña A, Tansey MG, Walker KA.

Mol Neurodegener. 2025 Mar 31;20(1):39. doi: 10.1186/s13024-025-00828-x.

Infections, genetics, and Alzheimer's disease: Exploring the pathogenic factors for innovative therapies

Kordi R, Andrews TJ, Hicar MD.

Virology. 2025 Jun;607:110523. doi: 10.1016/j.virol.2025.110523. Epub 2025 Mar 27.

Unveiling the Protective Roles of Melatonin on Glial Cells in the Battle Against Alzheimer's Disease-Insights from In Vivo and In Vitro Studies

Sirimaharaj N, Thiankhaw K, Chattipakorn N, Chattipakorn SC.

Mol Neurobiol. 2025 Aug;62(8):10414-10426. doi: 10.1007/s12035-025-04904-7. Epub 2025 Apr 10.

Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer's Disease

Saadh MJ, Muhammad FA, Alazzawi TS, Fahdil AA, Athab ZH, Tuxtayev J, Alsaikhan F, Farhood B.

Mol Neurobiol. 2025 Aug;62(8):10577-10613. doi: 10.1007/s12035-025-04833-5. Epub 2025 Apr 12.

Functionalized Nanoparticles: A Promising Approach for Effective Management of Alzheimer's Disease

Bogadi S, Bhaskaran M, Ravichandran V, Nesamony J, Chelliah S, Kuppusamy G, Prakash GM, Karri VVSR, Mallick S, Farahim F, Ali T, Babu DR, Subramaniyan V.

Mol Neurobiol. 2025 Aug;62(8):10915-10934. doi: 10.1007/s12035-025-04917-2. Epub 2025 Apr 16.

Intervention points for the role of physical activity in prevention and treatment of Alzheimer's disease

Brendborg N, Febbraio MA.

J Physiol. 2026 Mar;604(6):2411-2420. doi: 10.1113/JP286747. Epub 2025 Apr 16.

Reactive Oxygen Species as a Common Pathological Link Between Alcohol Use Disorder and Alzheimer's Disease with Therapeutic Implications

Song H, Lee J, Lee Y, Kim S, Kang S.

Int J Mol Sci. 2025 Apr 1;26(7):3272. doi: 10.3390/ijms26073272.

What Information do Systemic Pathological Changes Bring to the Diagnosis and Treatment of Alzheimer's Disease?

Zhou J, Sun X, Wang K, Shen M, Yu J, Yao Q, Hong H, Tang C, Wang Q.

Neurosci Bull. 2025 Jul;41(7):1289-1301. doi: 10.1007/s12264-025-01399-z. Epub 2025 Apr 21.

Alzheimer's Disease and Polymeric Nanocarriers: Synergistic Advances in Targeted Drug Delivery

Kumar L, Rana R, Shaikh NK, Thakur A, Kashyap S, Aggarwal V, Jyothiraditya V.

Curr Top Med Chem. 2025;25(24):2829-2847. doi: 10.2174/0115680266347890250409153450.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias